242 filings
Page 6 of 13
DEFA14A
GRI
GRI Bio Inc
4 Apr 23
Additional proxy soliciting materials
7:19pm
8-K
GRI
GRI Bio Inc
4 Apr 23
Other Events
9:01am
425
GRI
GRI Bio Inc
4 Apr 23
Business combination disclosure
8:53am
DEFA14A
GRI
GRI Bio Inc
3 Apr 23
Additional proxy soliciting materials
4:05pm
8-K
GRI
GRI Bio Inc
31 Mar 23
Other Events
4:35pm
424B3
GRI
GRI Bio Inc
31 Mar 23
Prospectus supplement
4:33pm
DEFA14A
GRI
GRI Bio Inc
30 Mar 23
Additional proxy soliciting materials
4:09pm
DEFA14A
GRI
GRI Bio Inc
23 Mar 23
Additional proxy soliciting materials
4:04pm
EFFECT
GRI
GRI Bio Inc
9 Mar 23
Notice of effectiveness
12:15am
424B3
GRI
GRI Bio Inc
8 Mar 23
Prospectus supplement
4:18pm
S-4/A
GRI
GRI Bio Inc
Registration of securities issued in business combination transactions (amended)
6 Mar 23
4:38pm
CORRESP
GRI
GRI Bio Inc
6 Mar 23
Correspondence with SEC
12:00am
8-K
GRI
GRI Bio Inc
2 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
GRI
GRI Bio Inc
24 Feb 23
Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial Results
7:34am
S-4/A
GRI
GRI Bio Inc
Registration of securities issued in business combination transactions (amended)
24 Feb 23
6:05am
CORRESP
GRI
GRI Bio Inc
24 Feb 23
Correspondence with SEC
12:00am
10-K
2022 FY
GRI
GRI Bio Inc
Annual report
23 Feb 23
9:58pm
UPLOAD
GRI
GRI Bio Inc
14 Feb 23
Letter from SEC
12:00am
SC 13G/A
GRI
GRI Bio Inc
13 Feb 23
Vallon Pharmaceuticals / Lind Global Fund II ownership change
4:30pm